This is especially important if you have diabetes, take glucose-lowering medicines, have a history of pancreatitis or gallbladder disease, have severe gastrointestinal symptoms, or have kidney problems
In the STEP2 focusing on 1,210 patients with obesity or overweight and T2D, average weight loss with semaglutide 2.4 mg therapy was 6.2% compared to the placebo [47]
E11.9 with Z79.4: Type 2 diabetes, uncontrolled or unspecified, patient on long-term insulin E11.65 with Z79.4: Type 2 diabetes with hyperglycemia, patient on long-term insulin E11.649 with Z79.4: Type 2 diabetes with hypoglycemia without coma, patient on long-term insulin E11.40 with Z79.4: Type 2 diabetes with diabetic neuropathy, patient on long-term insulin Z79.4 is sequenced after the primary E11 combination code
The answer is probably both direct and indirect, Habegger said